By integrating genetic, biochemical, and biomechanical data, practitioners can develop more personalized and effective prevention strategies
Tirzepatide is known to aid in weight loss efforts by regulating appetite and potentially improving glycemic control, which can reduce excess weight associated with insulin resistance
[11] Any future GLP-1 patch would require robust clinical trial evidence demonstrating efficacy, safety, and pharmacokinetic profiles comparable to existing injectable formulations before regulatory approval could be granted
They share similar side effects, including nausea, vomiting, and digestive discomfort, especially during dose adjustments
doi: 10.1016/j.jdiacomp.2017.05.013 51 Moschovaki FilippidouFKirschAHThelenMKtszeriMArtingerKAringerIet al